These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 26606401)

  • 1. Immuno-Northern Blotting: Detection of RNA Modifications by Using Antibodies against Modified Nucleosides.
    Mishima E; Jinno D; Akiyama Y; Itoh K; Nankumo S; Shima H; Kikuchi K; Takeuchi Y; Elkordy A; Suzuki T; Niizuma K; Ito S; Tomioka Y; Abe T
    PLoS One; 2015; 10(11):e0143756. PubMed ID: 26606401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-Northern Blotting: Detection of Modified RNA Using Gel Separation and Antibodies to Modified Nucleosides.
    Mishima E; Abe T
    Methods Mol Biol; 2019; 1870():179-187. PubMed ID: 30539555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of monoclonal antibodies against N6-methyladenosine for the detection of RNA modifications.
    Matsuzawa S; Wakata Y; Ebi F; Isobe M; Kurosawa N
    PLoS One; 2019; 14(10):e0223197. PubMed ID: 31577817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existence of Diverse Modifications in Small-RNA Species Composed of 16-28 Nucleotides.
    Lan MD; Xiong J; You XJ; Weng XC; Zhou X; Yuan BF; Feng YQ
    Chemistry; 2018 Jul; 24(39):9949-9956. PubMed ID: 29756662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Northern hybridization: a proficient method for detection of small RNAs and microRNAs.
    Iram S
    Methods Mol Biol; 2014; 1099():179-88. PubMed ID: 24243204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing methods and functional decoding of mRNA modifications.
    Li K; Peng J; Yi C
    Fundam Res; 2023 Sep; 3(5):738-748. PubMed ID: 38933299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation modifications in eukaryotic messenger RNA.
    Liu J; Jia G
    J Genet Genomics; 2014 Jan; 41(1):21-33. PubMed ID: 24480744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high-throughput quantitative approach reveals more small RNA modifications in mouse liver and their correlation with diabetes.
    Yan M; Wang Y; Hu Y; Feng Y; Dai C; Wu J; Wu D; Zhang F; Zhai Q
    Anal Chem; 2013 Dec; 85(24):12173-81. PubMed ID: 24261999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Method for Measuring RNA N 6-methyladenosine Modifications in Cells and Tissues.
    Wang CY; Lin MH; Su HT
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular and immunological approach to hematological disease: detection and analysis of intracellular modified nucleosides by flow cytometry].
    Hoshino A; Honda I; Ishimori A; Itoh K; Mizugaki M; Nose M
    Rinsho Byori; 1990 Jul; 38(7):756-64. PubMed ID: 2402080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Main RNA Methylation in Hepatocellular Carcinoma: N6-Methyladenosine, 5-Methylcytosine, and N1-Methyladenosine.
    Xu Y; Zhang M; Zhang Q; Yu X; Sun Z; He Y; Guo W
    Front Cell Dev Biol; 2021; 9():767668. PubMed ID: 34917614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
    Liu C; Yang S; Zhang Y; Wang C; Du D; Wang X; Liu T; Liang G
    Cancer Manag Res; 2021; 13():7101-7114. PubMed ID: 34526822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of RNA modification in hepatocellular carcinoma.
    Feng Q; Wang D; Xue T; Lin C; Gao Y; Sun L; Jin Y; Liu D
    Front Pharmacol; 2022; 13():984453. PubMed ID: 36120301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pivotal regulatory landscape of RNA modifications.
    Li S; Mason CE
    Annu Rev Genomics Hum Genet; 2014; 15():127-50. PubMed ID: 24898039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles of RNA methylation in gastrointestinal cancers.
    Xie S; Chen W; Chen K; Chang Y; Yang F; Lin A; Shu Q; Zhou T; Yan X
    Cancer Cell Int; 2020 Dec; 20(1):585. PubMed ID: 33372610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.
    Tang C; Klukovich R; Peng H; Wang Z; Yu T; Zhang Y; Zheng H; Klungland A; Yan W
    Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E325-E333. PubMed ID: 29279410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antibodies specific for N6-methyladenosine and for 7-methylguanosine.
    Munns TW; Liszewski MK; Sims HF
    Biochemistry; 1977 May; 16(10):2163-8. PubMed ID: 861202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
    Shi H; Chai P; Jia R; Fan X
    Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody nucleic acid complexes. Immunospecific retention of N6-methyladenosine-containing transfer ribonucleic acid.
    Munns TW; Liszewski MK; Oberst RJ; Sims HF
    Biochemistry; 1978 Jun; 17(13):2573-8. PubMed ID: 354691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers.
    Rong D; Sun G; Wu F; Cheng Y; Sun G; Jiang W; Li X; Zhong Y; Wu L; Zhang C; Tang W; Wang X
    Mol Ther Nucleic Acids; 2021 Sep; 25():67-82. PubMed ID: 34188972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.